Shanghai King-cell Biotechnology Co. Ltd.

China

 
Total IP 6
Total IP Rank # 256,761
IP Activity Score 1.7/5.0    8
IP Activity Rank # 114,725

Patents

Trademarks

2 0
0 0
4 0
0
 
Last Patent 2022 - Device for evaluating neurovirul...
First Patent 2020 - F-genotype mumps virus attenuate...

Latest Inventions, Goods, Services

2022 Invention Construction of f gene-replaced chimeric measles attenuated strain. Provided are a construction m...
Invention Construction of h-gene-replaced chimeric measles attenuated strain. Provided are a construction m...
2020 Invention Device for evaluating neurovirulence of mumps virus. A device for evaluating the neurovirulence ...
Invention F-genotype mumps virus attenuated strain and construction method therefor and application thereof...
Invention Device for evaluating neurovirulence of mumps virus. A device for evaluating the neurovirulence o...